Best Value Stocks to Buy for July 1st

Zacks highlights three Zacks Rank #1 value stocks—Daktronics (DAKT), EnerSys (ENS), and Macy’s (M)—all trading at relatively low P/E multiples (DAKT 12.35 vs S&P 500 22.11; ENS 11.84 vs industry 17.50; Macy’s 6.88 vs industry 12.10). Consensus earnings estimates for these names have risen over the past 60 days (DAKT +34.5%, ENS +3.9%, Macy’s +8.6%). The article frames these as buy-rank picks with upside potential but provides no new financial results or guidance changes.

Analysis

This reads more like a factor-promo than a fundamental catalyst, so the main market effect is likely short-term attention and liquidity into low-multiple names rather than a durable re-rate. The near-term beneficiary is the basket of neglected, smaller-cap value stocks that can attract incremental retail flow; the loser is anyone who chases the screen without a path to estimate sustainability. Of the three, the most interesting is the one with the cleanest revision trend and least balance-sheet friction; the weakest is the name where cheapness may simply reflect secular traffic or margin decay.

Over the next 1-3 months, the real test is whether these estimate moves convert into forward guidance or just reflect model noise. For DAKT, the key question is whether display/project revenue can stay supported through the next capex cycle; if not, the multiple stays cheap despite headline revisions. ENS is the more defensible quality/value case because industrial replacement demand and backup power demand can support cash generation, but it needs continued pricing discipline to avoid being just another low-P/E industrial.

Contrarian view: the market often mistakes low P/E for mispricing when it is actually a signal of terminally lower growth. That is most relevant for M, where any valuation support can disappear quickly if consumer credit, promotion intensity, or inventory discipline worsens. The article’s real signal is not that all three are buys, but that value dispersion is widening; the winner will be the company with the strongest next-12-month free-cash-flow visibility, not the one with the lowest screen multiple.

Key Decisions for Investors

• Prefer ENS over M on a 1-3 month relative-value basis: long ENS / short M to express quality-within-value; target 10-15% relative outperformance if industrial demand holds and consumer margins soften.
• Treat DAKT as a tactical watchlist name, not a core long: only buy on a volume-confirmed pullback or a follow-through from estimate revisions; invalidation if the next update shows order delays or guidance hesitation.
• Do not chase the broad 'cheap stocks' basket without confirmation: wait for 2+ sessions of relative strength in IWD vs IWF before considering a factor rotation trade.
• If already long M, tighten risk: the thesis breaks on any further gross margin compression or softer consumer credit commentary over the next earnings cycle.
• For ENS, any long should be sized as a quality-value compounder, not a momentum trade; revisit if pricing/mix commentary weakens or if revisions stop rising over the next quarter.